The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial.   In a Phase 3 study, the ...

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...

The Cambridge biotech believes packaging the two immunizations together will lead to higher uptake of COVID vaccines.

The new results helped boost Moderna’s stock by more than 4% in early trading Monday, though the company’s shares are still ...

Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...

The Department of Agriculture has issued its first-ever permit to vaccinate poultry against highly pathogenic avian influenza ...

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...

Newborns are at risk for serious complications from influenza infections but are not eligible for vaccination until they are ...

Without protocol reforms, mass vaccinations of the national flock will be unlikely. Astral Foods became the first broiler ...

Moderna is preparing to test Health Secretary Robert F. Kennedy Jr.'s tougher vaccine policies with a combination flu-COVID ...

Moderna has reported positive phase 3 results for its seasonal flu vaccine, mRNA-1010, which outperformed a standard-dose ...